Hadassah

Hadassah Heart Specialists Reveal Detrimental Effect of Thyroid Imbalance on Heart Failure Patients

Wednesday, Apr 23 2014


A study by the Hadassah Medical Organization's heart specialists has revealed that increased levels of thyroid-stimulating hormone (TSH) are correlated with "worse clinical outcome" in patients suffering from heart failure. "Thyroid imbalance," they report, "confers significant risk in heart failure and warrants attention." While it has been known that thyroid dysfunction affects cardiac function and is a risk factor for heart failure, the scientists report, "data regarding the clinical significance of TSH levels alone as a predictor of outcome in patients with heart failure is sparse." Their study evaluated the significance of TSH on clinical outcome in a large cohort of patients with chronic heart failure.

Study findings reveal that both a high and a low TSH level are associated with an increased mortality rate. In addition, TSH was also an independent predictor of death and cardiac-related hospitalization. For those patients not receiving thyroid hormone treatment, "TSH was an even stronger predictor of mortality." At the same time, increasing TSH levels above normal were "independently associated with increased mortality and cardiac-related hospitalizations." The study, entitled "The Effect of Thyroid Function on Clinical Outcome in Patients with Heart Failure," was published in the February 2014 issue of the European Journal of Heart Failure (Volume 16, Issue 2).

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More